Home7AY1 • FRA
add
Actinium Pharmaceuticals Inc
Previous close
€1.33
Day range
€1.26 - €1.26
Year range
€1.00 - €9.80
Market cap
47.73M USD
Avg Volume
261.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.64M | 73.37% |
Net income | -15.94M | -83.83% |
Net profit margin | — | — |
Earnings per share | -0.51 | -64.52% |
EBITDA | -16.43M | -75.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.32M | -22.28% |
Total assets | 68.65M | -22.30% |
Total liabilities | 42.95M | -3.47% |
Total equity | 25.69M | — |
Shares outstanding | 31.20M | — |
Price to book | 1.62 | — |
Return on assets | -57.16% | — |
Return on capital | -135.36% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.94M | -83.83% |
Cash from operations | -7.57M | -2.71% |
Cash from investing | — | — |
Cash from financing | -2.00K | -100.01% |
Net change in cash | -7.58M | -202.61% |
Free cash flow | -1.90M | 58.63% |
About
CEO
Founded
2000
Website
Employees
31
